Where GoodRx Holdings Stands With Analysts
Portfolio Pulse from Benzinga Insights
GoodRx Holdings (NASDAQ:GDRX) has received 4 indifferent analyst ratings in the last quarter, with no bullish or bearish ratings. The average 12-month price target for GDRX is $6.0, which is a 17.24% decrease from the previous target of $7.25. The high target is $7.00 and the low is $5.50. Analysts rate stocks based on research and provide guidance which is subject to their own discretion and may vary each quarter.
November 10, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
GoodRx Holdings has seen a downward revision in the average analyst price target to $6.0, indicating a potential negative sentiment in the short term.
The reduction in the average price target for GoodRx Holdings suggests that analysts are less optimistic about the stock's future performance. This could lead to a negative short-term impact on the stock price as investors adjust their expectations. The unanimous indifferent rating further solidifies the potential for a negative impact.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100